Attention Deficit Hyperactivity Disorder
Cluster Number:
Wiki Number: W016
Diagnosis: ADHD-Attention Deficit Hyperactivity Disorder
US Patients:
World Patients: 51Mil
Sex Ratio: B2;G1
Age Onset: Age5-12
Brain Area: left prefrontal cortex, posterial parietal cortex;, accumbens, amygdala, hippocampus smaller
Symptoms: Hard to pay attention or control behavior; impulsive. Higher creativity
Progression: 9 points lower IQ scores; higher in dynamic energy and adventurousness, 40% in adults
Causes: 75% genetic; dopamine less-well regulated in boys; norepinephrine less well-regulated in girls; adult ADHD-neither
Medications: amphetamines to keep students quiet in schools for boys; stimulants increase blood flow, perk up the girls
Therapies: behavioral therapies, parent training
Youtube Video: ADHD – Finding What Works for Me
Youtube Video:
The Signs of Adult ADHD
Jim Lohr’s own downloads for ADHD are for sale in the “Blue Box,”
also on this website.
Taming My Hyperactive ADHD!
Overcoming My Inattentive ADHD!
Controlling My Adult ADHD!
You can order any or all of these downloads from the “Blue Box” in the right column of the website.
Amazon or Library Book:
A Dragon with ADHD
Amazon or Library Book:
Thriving with Adult ADHD
Click the book to link or order from Amazon.
Click the book to link or order from Amazon.
Support Group: add.org (Attention Deficit Disorder Association)
Contact your school for Special Education under the
U.S. Department of Education’s
Individuals with Disabilities Education Act, Section 300.8.
4 CURRENT ARTICLES
FROM PUBMED
The world-wide medical research
reports chosen for each diagnosis
Clicking each title opens the
PubMed article’s summary-abstract.
- Methylphenidate abuse and misuse in patients affected with a psychiatric disorder and a substance use disorder: a systematic reviewby Stefania Chiappini on December 3, 2024
CONCLUSION: MPH misuse and abuse are significant concerns in patients with psychiatric disorders and SUD. Risk factors include impulsivity, history of substance abuse, and access to prescription stimulants. Integrated therapeutic approaches and stricter prescription monitoring are recommended to mitigate misuse risks.
- A multicenter, single-group, open feasibility study of a new individual cognitive behavioral therapy program for adult Japanese patients with attention-deficit/hyperactivity disorder: Study protocolby Naoki Takamatsu on December 3, 2024
CONCLUSIONS: This study is essential for the development of CBT interventions in accordance with Japan's healthcare system that are tailored to the unique needs of its population.
- Spectrum of neuropsychological challenges in Turner syndromeby Jacqueline I Fezza on December 3, 2024
INTRODUCTION: Turner syndrome (TS) is associated with significant neuropsychological challenges, and screening is recommended at key transition stages. Our goal was to describe the institutional experience of formal neuropsychological assessments in TS and assess differences by karyotype.
- Aberrant extracellular dopamine clearance in the prefrontal cortex exhibits ADHD-like behavior in NCX3 heterozygous miceby Ryo Inagaki on December 3, 2024
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder that involves dopaminergic dysfunction in the prefrontal cortex (PFC), manifesting hyperactivity, inattention, and cognitive deficits. However, the ADHD-associated candidate genes underlying dopaminergic neurotransmission alterations remain poorly defined. Here, we identified the abundant localization of sodium-calcium exchanger 3 (NCX3) levels in the dopaminergic neurons of the ventral tegmental area, a major...